Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01600430 · ClinicalTrials.gov registry record · Phase 2
Vitamin D Supplementation for Extremely Preterm Infants
A Phase 2 study of Vitamin D Deficiency and Bronchopulmonary Dysplasia, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT01600430 is a Phase 2 study of Vitamin D Deficiency and Bronchopulmonary Dysplasia that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants, below the 274-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01600430, a Phase 2 study of Vitamin D Deficiency and Bronchopulmonary Dysplasia, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The study hypothesis states that giving early enteral Vitamin D supplementation to preterm infants will decrease respiratory morbidity in extremely preterm infants.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Cholecalciferol
- DIETARY_SUPPLEMENT Placebo
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01600430
The ClinicalTrials.gov registry entry for NCT01600430 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 274-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (64% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Vitamin D Deficiency appearing as the primary indexed condition, and to 2 interventions - of which Cholecalciferol is the first listed.
NCT01600430 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT01600430 about?
NCT01600430 is a clinical study titled "Vitamin D Supplementation for Extremely Preterm Infants". The study hypothesis states that giving early enteral Vitamin D supplementation to preterm infants will decrease respiratory morbidity in extremely preterm infants.
What is the current status of trial NCT01600430?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2012-06. Estimated completion is 2016-12.
What conditions does trial NCT01600430 study?
This clinical trial studies the following conditions: Vitamin D Deficiency, Bronchopulmonary Dysplasia, Preterm Infants.
What interventions are being tested in trial NCT01600430?
The interventions under investigation include: Cholecalciferol (DIETARY_SUPPLEMENT), Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01600430?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01600430 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitamin D Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
RECRUITING · Phase 2
-
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
RECRUITING · Phase 2
-
High-dose Vitamin D Supplements in Older Adults
ACTIVE NOT RECRUITING · Phase 2
-
Vitamin D for Sickle-cell Respiratory Complications
COMPLETED · Phase 2
-
Hypovitaminosis D in Neurocritical Patients
COMPLETED · Phase 2
-
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.